Novo Nordisk A/S (NVO)
48.73
-0.39
(-0.79%)
USD |
NYSE |
Feb 11, 16:00
48.81
+0.08
(+0.16%)
After-Hours: 20:00
Novo Nordisk Total Assets (Quarterly) : 85.37B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ascendis Pharma A/S | 1.357B |
| Evaxion AS | 25.24M |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Viking Therapeutics, Inc. | 739.42M |
| DBV Technologies SA | 110.50M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 54.85B |
| Shareholders Equity (Quarterly) | 30.51B |
| Debt to Equity Ratio | 0.6749 |
| Current Ratio | 0.7996 |
| Net Debt Paydown Yield | -1.07% |